Safety and immunogenicity of bivalent RSVpreF vaccine formulated in a multidose vial in healthy female participants in the USA: a multicentre, randomised, open-label, noninferiority phase 3 study
Authors
Y Liu
Elena Kalinina (ORCID: https://orcid.org/0000-0003-0180-090X)
Safety and immunogenicity of bivalent RSVpreF vaccine formulated in a multidose vial in healthy female participants in the USA: a multicentre, randomised, open-label, noninferiority phase 3 study
Y Liu, Elena Kalinina, Lisa Steffany Pinheiro Pereira, Sandra Pagnussat et al.
Journal
EClinicalMedicine
Topics
Parvovirus B19 Infection Studies
article
Safety and immunogenicity of bivalent RSVpreF vaccine formulated in a multidose vial in healthy female participants in the USA: a multicentre, randomised, open-label, noninferiority phase 3 study
Y Liu, Elena Kalinina, Lisa Steffany Pinheiro Pereira, Sandra Pagnussat, Shyam Ajay Patel, Iona Munjal, Uzma Sarwar, Emma Shittu, Jeffrey B. Baker, David Strong, Jon Finley, Alejandra Gurtman, Kena A. Swanson, Olympia Evdoxia Anastasiou, Annaliesa S. Anderson
article en
Abstract
No abstract available for this paper.
Publication Tag
EClinicalMedicineVol. 92
Institutions
Pfizer (United States) (US), Eastern Idaho Technical College (US), Clinical Research Atlanta (US), Allergan (United Kingdom) (GB), Miami-Dade County Public Schools (US), Northwestern Medicine (US)